Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Highlights: Therapeutic antibodies for Ebola were isolated from human donors in a vaccine trial The derived antibodies were close to germline in sequence Despite temporal immaturity, their binding kinetics matched established antibodies Vaccine trials can provide a golden opportunity to isolate therapeutic antibodies

More information Original publication

DOI

https://doi.org/10.1016/j.celrep.2019.03.020

Type

Alumni publications

Publisher

Cell

Publication Date

02/04/2019

Volume

27

Keywords

Ebola, vaccine trial, therapeutic antibodies